Compared with CD39low T cells, the time-to-first treatment of CLL patients with CD39high T cells is significantly shorter, which indicates that the expression of CD39 on CD4+ T cells is closely related to the more advanced stage of the disease and that CD39 plays a role in the invasion of the disease (71, 72). The gene discussed is CD4; the disease is B-cell chronic lymphocytic leukemia.